<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>The usefulness of dynamic perfusion computerized tomography for early diagnosis of <z:hpo ids='HP_0001297'>stroke</z:hpo> is well established </plain></SENT>
<SENT sid="1" pm="."><plain>However, limited data exists to assess the value of PCT in the evaluation of patients with <z:hpo ids='HP_0011010'>chronic</z:hpo> <z:hpo ids='HP_0002637'>cerebral ischemia</z:hpo> </plain></SENT>
<SENT sid="2" pm="."><plain>The purpose of the study was to assess the utility of perfusion computerized tomography with <z:chebi fb="0" ids="27690">acetazolamide</z:chebi> challenge (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">PCTA</z:e>) in the evaluation of cerebral perfusion and cerebrovascular reserve (CVR) in adult <z:e sem="disease" ids="C0026654" disease_type="Disease or Syndrome" abbrv="MYMY|MYMY1">Moyamoya</z:e> patients </plain></SENT>
<SENT sid="3" pm="."><plain>From 2005-2008, 41 patients with <z:e sem="disease" ids="C0026654" disease_type="Disease or Syndrome" abbrv="MYMY|MYMY1">Moyamoya</z:e> were scrutinized by <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">PCTA</z:e> </plain></SENT>
<SENT sid="4" pm="."><plain>Of these, 22 patients (12 females, ten males, mean age 41 years) with ischemic symptoms from <z:e sem="disease" ids="C0026654" disease_type="Disease or Syndrome" abbrv="MYMY|MYMY1">Moyamoya disease</z:e> were found to have no response or decreased cerebrovascular flow post-<z:chebi fb="0" ids="27690">acetazolamide</z:chebi> indicating compromised CVR </plain></SENT>
<SENT sid="5" pm="."><plain>Eight had bilateral symptoms </plain></SENT>
<SENT sid="6" pm="."><plain>Based on matching symptoms and decreased CVR on <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">PCTA</z:e>, those 22 patients underwent 30 superficial temporal artery-to-middle cerebral artery (STA-<z:chebi fb="70" ids="34342">MCA</z:chebi>) by-pass (eight with bilateral abnormal <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">PCTA</z:e> had bilateral STA-<z:chebi fb="70" ids="34342">MCA</z:chebi> by-pass) </plain></SENT>
<SENT sid="7" pm="."><plain>After a mean follow-up of 14 months (range, 3-36 months), no new <z:hpo ids='HP_0001297'>strokes</z:hpo> or symptoms were reported </plain></SENT>
<SENT sid="8" pm="."><plain>Graft patency, as documented by postoperative computerized tomography angiography at a mean 12 weeks after surgery was 100% </plain></SENT>
<SENT sid="9" pm="."><plain>Eight patients had postoperative <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">PCTA</z:e> documenting improved CVR after STA-<z:chebi fb="70" ids="34342">MCA</z:chebi> by-pass </plain></SENT>
<SENT sid="10" pm="."><plain>At latest follow-up, none of the 19 patients with <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">PCTA</z:e> findings suggestive of <z:mpath ids='MPATH_458'>normal</z:mpath> CVR had any ischemic symptoms </plain></SENT>
<SENT sid="11" pm="."><plain>CVR testing by means of <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">PCTA</z:e> may have a key role in patient selection for revascularization surgery and postoperative follow-up </plain></SENT>
<SENT sid="12" pm="."><plain>These promising results warrant further testing of the technique </plain></SENT>
</text></document>